Abstract: In this research, we introduce a deep reinforcement learning-based control approach to address the intricate challenge of the robotic pre-grasping phase under microgravity conditions.
In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.
Clinical research technology veteran joins to accelerate company's growth as the unified platform solution for ...
Mona.py is a python script that can be used to automate and speed up specific searches while developing exploits (typically for the Windows platform). It runs on Immunity Debugger and WinDBG, and ...
The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...
Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...
New genetic research has identified a direct causal chain connecting the microorganisms in the human digestive tract to the ...
Ocular Therapeutix Inc. (NASDAQ:OCUL) is a biopharmaceutical company that develops and commercializes therapies for retinal ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.
Abstract: In the past decades, the rise of artificial intelligence has given us the capabilities to solve the most challenging problems in our day-to-day lives, such as cancer prediction and ...